Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Technology
Technology

Tempus AI Receives 510(k) Clearance From FDA For Tempus ECG-MR, AI Product That Analyzes Standard 12-Lead Resting Ecgs To Detect Signs Associated With Undiagnosed Mitral Regurgitation

Sep 28, 2026 · 08:06 AM ET· updated 1h ago

ECG-MR becomes the fourth FDA-cleared Tempus ECG-AI product, spanning arrhythmia, heart function, pulmonary vascular and valvular diseaseTempus AI, Inc. (NASDAQ:TEM) today announced it has received 510(k) clearance from

Share
Why It Matters

Tempus AI got government approval for a new heart tool. It uses AI to spot a heart valve problem from simple heart tests.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
TEM84.06
-0.95 (-1.12%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.